Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 124 results found. Search for [ COVID-19 vaccine Gamaleya ]

Results 80 to 100 of 124
Chitranjan Kumar
September 16, 2020
The Sputnik V vaccine, developed by the Gamaleya research institute in coordination with the Russian defence ministry, is the world's first registered vaccine against COVID-19 based on the human adenoviral vectors platform


BusinessToday.In
September 15, 2020
The head of the world's largest vaccine manufacturer said that the world will need 15 billion doses of the COVID-19 shot if it is a two-dose vaccine


BusinessToday.In
September 9, 2020
Dr VK Paul informed the Russian government has approached India to facilitate the Phase-3 trial of their vaccine and also manufacture Sputnik V through Indian companies


BusinessToday.In
September 8, 2020
On 11 August, the world's first vaccine against the COVID-19 'Sputnik V' was registered by the Russian government. The vaccine is developed by  Gamaleya National Research Center of Epidemiology and Microbiology and the Russian Direct Investment Fund (RDIF)


BusinessToday.In
September 7, 2020
Moscow-based Gamaleya Research Institute of Epidemiology and Microbiology, which has developed the inoculation, has submitted \"comprehensive data\" on its safety and efficacy to Indian authorities


BusinessToday.In
September 6, 2020
Russia's medical watchdog Roszdravnadzor will soon assess vaccine for quality check and could get approval by September 13, following which government will authorise vaccine for civilian use


BusinessToday.In
September 1, 2020
COVID-19 vaccine: The University of Oxford and AstraZeneca PLC has developed the first vaccine candidate to start the final round of testing of the coronavirus vaccine


Reuters
September 1, 2020
Many experts expressed skepticism about the Russian vaccine after the government declared its intention to give it to high-risk groups in October without data from large pivotal trials


Associated Press
August 27, 2020
Scientists at the World Health Organization said last week that although they had begun discussions with Russia about its vaccine, they had not yet received any detailed data about it


BusinessToday.In
August 25, 2020
Coronavirus vaccine news update: Russian Ambassador Nikolai Kudashev reached out to India on Tuesday seeking a partnership in the production of coronaviru vaccine Sputnik V


BusinessToday.In
August 21, 2020
Coronavirus vaccine update: Serum Institute of India that is manufacturing the Oxford University-AstraZeneca vaccine will conductt the trials wouldon 1,600 healthy volunteers with no history of COVID-19


BusinessToday.In
August 21, 2020
RDIF CEO Kirill Dmitriev said that Russia currently has the capacity of 500 million doses per year, but plans to increase this capacity


BusinessToday.In
August 19, 2020
Kirill Dmitriev, CEO of the Russian Direct Investment Fund said Russia is in touch with Indian regulators and manufacturers to produce the COVID-19 vaccine in India


PTI
August 17, 2020
Sputnik V has been developed by the Gamaleya Research Institute of Epidemiology and Microbiology along with the Russian Direct Investment Fund (RDIF)


BusinessToday.In
August 17, 2020
Coronavirus vaccine news update: Russia has produced the first batch of COVID-19 vaccine, Sputnik V, the health ministry said. The country said that the vaccine will be rolled out by end of month


BusinessToday.In
August 17, 2020
Last month, the medical journal Lancet wrote that the Phase-2 clinical trial of CanSino Biologics' adenovirus vector vaccine or Ad5-nCoV was safe and induced immune response


BusinessToday.In
August 16, 2020
Russia's health ministry said in a statement on Saturday that the first batch of the indigenously developed coronavirus vaccine, developed by the Gamaleya research institute has been produced


BusinessToday.In
August 15, 2020
Russia's COVID-19 vaccine, which was developed by Moscow's Gamaleya Institute, will be rolled out by the end of August


PB Jayakumar
August 14, 2020
The Western world and the big pharma are upset. They say Russia has not done adequate safety and efficacy studies and the claim is based on testing on less than 100 human volunteers


BusinessToday.In
August 14, 2020
Professor Alexander Chuchalin resigned from the health ministry's ethics council after trying to block the registration of what Russia claims to be 'world's first coronavirus vaccine' on 'safety grounds'


PAGES 5 OF 7  12345